Latest News about Breaking News
Recent news which mentions Breaking News
J&J backs out of RSV vaccine race with rivals Pfizer and GSK
March 29, 2023
From CNBC.com News
Carl Icahn wants to bring back Illumina's ex-CEO 'immediately' as proxy fight intensifies
March 29, 2023
From CNBC.com News
Stocks making the biggest moves premarket: Lululemon, Paychex, Micron Technology and more
March 29, 2023
From CNBC.com News
Lyft CEO and president to step down in mid-April, former Amazon exec David Risher named as replacement
March 27, 2023
From CNBC.com News
Labcorp to pay $2.1 million to settle allegations it overbilled Defense Department for genetic tests for military members
March 27, 2023
From CNBC.com News
BioNTech shares slip on gloomy Covid vaccine sales outlook
March 27, 2023
From CNBC.com News
From CNBC.com News
Nearly $100 billion in deposits pulled from banks; officials call system 'sound and resilient'
March 24, 2023
From CNBC.com News
Wyoming abortion ban blocked due to Obamacare-era amendment
March 24, 2023
From CNBC.com News
Carl Icahn claims Illumina directors got extra insurance to close 'disastrous' $7.1 billion Grail deal
March 24, 2023
From CNBC.com News
Pfizer's Covid drug Paxlovid may reduce the risk of developing long Covid, study says
March 24, 2023
From CNBC.com News
Sam Altman didn't take any equity in OpenAI, report says
March 24, 2023
From CNBC.com News
Sanofi, Regeneron shares pop more than 6% after data shows asthma drug Dupixent may also treat COPD
March 23, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
Stocks making the biggest moves midday: Nvidia, First Republic, Nike, GameStop and more
March 22, 2023
From CNBC.com News
Stocks making the biggest moves premarket: GameStop, Luminar Technologies, Virgin Orbit & more
March 22, 2023
From CNBC.com News
If you had Covid before you were vaccinated, you might have less immunity than you think, study says
March 21, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
March 20, 2023
From CNBC.com News
Biotech company Illumina pushes back against Carl Icahn’s proxy fight over $7.1 billion Grail deal
March 20, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.